Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population (FRONTIER-UC)

NCT07401680 PHASE1 NOT_YET_RECRUITING

This is a multi-centre, randomised controlled trial comparing fecal microbiota transplantation to placebo in an expanded ulcerative colitis population: a feasibility study (FRONTIER-UC) to determine whether a full-scale randomized controlled trial (RCT) to investigate fecal microbiota transplantation (FMT) in ulcerative colitis (UC) is feasible.

Details

Lead sponsor	University of Alberta
Phase	PHASE1
Status	NOT_YET_RECRUITING
Enrolment	85
Start date	Sun Mar 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Ulcerative Colitis
• Inflammatory Bowel Diseases
• Clostridioides Difficile Infection

Interventions

• Lyophilized Fecal Microbiota Transplantation (LFMT)
• Placebo

Countries

Canada